丹麦制药商诺和诺德公司(Novo Nordisk)周一宣布,即日起所有符合条件的美国自费患者均可在当地药房以每月499美元的折扣价购买减肥药Wegovy。最近诺和诺德公司的欧洲市值第一宝座已被德国软件巨头SAP取代。这家制药商与竞争对手礼来公司近期相继下调热门减肥药售价,以应对利润丰厚的减肥药市场竞争格局变化。投资者担忧礼来带来的竞争压力,以及诺和诺德下一代减肥药CagriSema(被寄望接棒...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.